Omicron-specific vaccine being developed by SII could be released by the end of the year: Report
An Omicron-specific vaccination is apparently being developed by the Serum Institute of India (SII), according to an NDTV report. The vaccine is being developed in collaboration with Novavax, according to SII Chief Executive Officer Adar Poonawalla, who spoke to NDTV. Poonawalla added that the vaccine would only protect against the Omicron sub-variant BA5. Poonawalla says …